Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 9/2004

01-09-2004 | Original Article

201Tl-SPECT in low-grade gliomas: diagnostic accuracy in differential diagnosis between tumour recurrence and radionecrosis

Authors: Manuel Gómez-Río, Dolores Martínez del Valle Torres, Antonio Rodríguez-Fernández, José Manuel Llamas-Elvira, Simeón Ortega Lozano, Carlos Ramos Font, Escarlata López Ramírez, Majed Katati

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 9/2004

Login to get access

Abstract

Purpose

The aim of this work was to describe the usefulness of a simple 201Tl single-photon emission computed tomography (SPECT) technique in the differential diagnosis between tumour recurrence and radionecrosis during the follow-up of patients treated for low-grade gliomas.

Methods

The study population comprised 84 patients treated for low-grade gliomas who showed suspicion of tumour recurrence during their follow-up. All patients were examined by neuro-anatomical imaging procedures (CT, MRI) and 201Tl-SPECT. 201Tl-SPECT images were assessed by visual analysis based only on the information on the prescription form and by estimation of the uptake index (ratio of mean counts in the lesion to those in the contralateral mirror area). Examiners were blinded to the results of other tests.

Results

Under these conditions, the neuro-anatomical procedures yielded 26.2% inconclusive reports, with a global diagnostic accuracy of 0.61, a sensitivity of 0.63 and a specificity of 0.59. The global diagnostic accuracy for 201Tl-SPECT was 0.83, with a sensitivity of 0.88 and a specificity of 0.76. Diagnostic pitfalls were observed in regions with physiological 201Tl uptake, i.e. the posterior cranial fossa, diencephalon, lateral ventricles and cavernous and longitudinal venous sinuses. An uptake index cut-off value of 1.25 showed a sensitivity of 0.90 and specificity of 0.80 for detection of tumour activity.

Conclusion

201Tl-SPECT has adequate diagnostic accuracy to be part of routine algorithms in the follow-up of patients with low-grade glioma suspected of tumour recurrence, as an alternative to neuro-anatomical procedures and not solely as a complementary test.
Literature
2.
go back to reference Recht LD, Bernstein M. Low-grade gliomas. Neurol Clin 1995; 14:847–860. Recht LD, Bernstein M. Low-grade gliomas. Neurol Clin 1995; 14:847–860.
3.
go back to reference Kleihues P, Cavenee WK, eds. Tumours of the nervous system. Pathology and genetics. Lyon: International Agency for Research on Cancer (IARC), 2000. Kleihues P, Cavenee WK, eds. Tumours of the nervous system. Pathology and genetics. Lyon: International Agency for Research on Cancer (IARC), 2000.
4.
go back to reference Ashby LS. Low-grade gliomas: when and how to treat. In: Perry MC, ed. American Society of Clinical Oncology. Educational Book. Alexandria (VA): ASCO; 2000:688–695. Ashby LS. Low-grade gliomas: when and how to treat. In: Perry MC, ed. American Society of Clinical Oncology. Educational Book. Alexandria (VA): ASCO; 2000:688–695.
5.
go back to reference Bénard F, Romsa J, Hustinx R. Imaging gliomas with positron emission tomography and single photon emission computed tomography. Semin Nucl Med 2003; 33:148–162.CrossRefPubMed Bénard F, Romsa J, Hustinx R. Imaging gliomas with positron emission tomography and single photon emission computed tomography. Semin Nucl Med 2003; 33:148–162.CrossRefPubMed
6.
go back to reference Kim KT, Black KL, Marciano D, et al. Thallium-201 SPECT imaging of brain tumors: methods and results. J Nucl Med 1990; 31:965–969.PubMed Kim KT, Black KL, Marciano D, et al. Thallium-201 SPECT imaging of brain tumors: methods and results. J Nucl Med 1990; 31:965–969.PubMed
7.
go back to reference Van Veelen Ml, Avezaat CJ, Kros JM, et al. Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation and the issue of early versus late surgery. J Neurol Neurosurg Psychiatry 1998; 64:581–587.PubMed Van Veelen Ml, Avezaat CJ, Kros JM, et al. Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation and the issue of early versus late surgery. J Neurol Neurosurg Psychiatry 1998; 64:581–587.PubMed
8.
go back to reference Soler C, Beachesne P, Maataougui K, et al. Technetium-99m sestamibi brain SPECT for detection of recurrent gliomas after radiation therapy. Eur J Nucl Med 1998; 25:1649–1657.PubMed Soler C, Beachesne P, Maataougui K, et al. Technetium-99m sestamibi brain SPECT for detection of recurrent gliomas after radiation therapy. Eur J Nucl Med 1998; 25:1649–1657.PubMed
9.
go back to reference Sasaki M, Kuwabara Y, Yoshida T, et al. A comparative study of thallium-201 SPECT, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours. Eur J Nucl Med 1998; 25:1261–1269.CrossRefPubMed Sasaki M, Kuwabara Y, Yoshida T, et al. A comparative study of thallium-201 SPECT, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours. Eur J Nucl Med 1998; 25:1261–1269.CrossRefPubMed
10.
go back to reference Rubinstein R, Karger H, Pietrzyk U, et al. Use of201thallium brain SPECT, imaging registration, and semi-quantitative analysis in the follow-up of brain tumors. Eur J Radiol 1996; 21:188–195.CrossRefPubMed Rubinstein R, Karger H, Pietrzyk U, et al. Use of201thallium brain SPECT, imaging registration, and semi-quantitative analysis in the follow-up of brain tumors. Eur J Radiol 1996; 21:188–195.CrossRefPubMed
11.
go back to reference Ricci PE. Imaging of adult brain tumors. Neuroimagin Clin North Am 1999; 9:651–669. Ricci PE. Imaging of adult brain tumors. Neuroimagin Clin North Am 1999; 9:651–669.
12.
go back to reference Nelson SJ. Imaging of brain tumors after therapy. Neuroimagin Clin North Am 1999; 9:801–819. Nelson SJ. Imaging of brain tumors after therapy. Neuroimagin Clin North Am 1999; 9:801–819.
13.
go back to reference Sugahara T, Korogi Y, Tomiguchi S, et al. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MRI for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. Am J Neuroradiol 2000; 21:901–909.PubMed Sugahara T, Korogi Y, Tomiguchi S, et al. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MRI for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. Am J Neuroradiol 2000; 21:901–909.PubMed
14.
go back to reference Black KL, Hawkins RA, Kim KT, et al. Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg 1989; 71:342–346.PubMed Black KL, Hawkins RA, Kim KT, et al. Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg 1989; 71:342–346.PubMed
15.
go back to reference Dierckx RA, Martin JJ, Dobbeleir A, et al. Sensitivity and specificity of thallium-201 SPECT in the functional detection and differential diagnosis of brain tumours. Eur J Nucl Med 1994; 21:621–633.PubMed Dierckx RA, Martin JJ, Dobbeleir A, et al. Sensitivity and specificity of thallium-201 SPECT in the functional detection and differential diagnosis of brain tumours. Eur J Nucl Med 1994; 21:621–633.PubMed
16.
go back to reference Isibashi M, Taguchi A, Sugita Y, et al. Thallium-201 in brain tumors: relationship between tumor cell activity in astrocytic tumor and proliferating cell nuclear antigen. J Nucl Med 1995; 36:2201–2206.PubMed Isibashi M, Taguchi A, Sugita Y, et al. Thallium-201 in brain tumors: relationship between tumor cell activity in astrocytic tumor and proliferating cell nuclear antigen. J Nucl Med 1995; 36:2201–2206.PubMed
17.
go back to reference Källén K, Heiling A-M, Brun A, et al. Preoperative grading of glioma malignancy with thallium-201 SPECT: comparison with conventional CT. Am J Neuroradiol 1996; 17:925–932.PubMed Källén K, Heiling A-M, Brun A, et al. Preoperative grading of glioma malignancy with thallium-201 SPECT: comparison with conventional CT. Am J Neuroradiol 1996; 17:925–932.PubMed
18.
go back to reference Da Sun, Liu Q, Liu W, et al. Clinical applications of201Tl-SPECT imaging of brain tumors. J Nucl Med 2000; 41:5–10.PubMed Da Sun, Liu Q, Liu W, et al. Clinical applications of201Tl-SPECT imaging of brain tumors. J Nucl Med 2000; 41:5–10.PubMed
19.
go back to reference Kline JL, Noto RN, Glantz M. SPECT in the evaluation of recurrent brain tumor in patients treated with gamma knife radiosurgery or conventional radiation therapy. Am J Neuroradiol 1996; 17:1681–1686.PubMed Kline JL, Noto RN, Glantz M. SPECT in the evaluation of recurrent brain tumor in patients treated with gamma knife radiosurgery or conventional radiation therapy. Am J Neuroradiol 1996; 17:1681–1686.PubMed
20.
go back to reference Oriuchi N, Tomiyoshi K, Inoue T, et al. Independent thallium-201 accumulation and fluorine-18-FDG metabolism in glioma. J Nucl Med 1996; 37:457–462.PubMed Oriuchi N, Tomiyoshi K, Inoue T, et al. Independent thallium-201 accumulation and fluorine-18-FDG metabolism in glioma. J Nucl Med 1996; 37:457–462.PubMed
21.
go back to reference Oriuchi N, Tamura M, Shibazaki T, et al. Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis and proliferative activities. J Nucl Med 1993; 34:2085–2089.PubMed Oriuchi N, Tamura M, Shibazaki T, et al. Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis and proliferative activities. J Nucl Med 1993; 34:2085–2089.PubMed
22.
go back to reference Moustafa HM, Omar WM, Ezzat I, et al.201Tl SPECT in the evaluation of residual and recurrent astrocytoma. Nucl Med Commun 1994; 15:140–143.PubMed Moustafa HM, Omar WM, Ezzat I, et al.201Tl SPECT in the evaluation of residual and recurrent astrocytoma. Nucl Med Commun 1994; 15:140–143.PubMed
23.
go back to reference Staffen W, Hondl N, Trinka E, et al. Clinical relevance of201Tl-chloride SPECT in the differential diagnosis of brain tumours. Nucl Med Commun 1998; 19:335–340.PubMed Staffen W, Hondl N, Trinka E, et al. Clinical relevance of201Tl-chloride SPECT in the differential diagnosis of brain tumours. Nucl Med Commun 1998; 19:335–340.PubMed
24.
go back to reference Stokkel M, Stevens H, Taphoorn M, et al. Differentiation between recurrent brain tumour and post-radiation necrosis: the value of201Tl-SPECT versus 18F-FDG PET using a dual-headed coincidence camera—a pilot study. Nucl Med Commun 1999; 20:411–417.PubMed Stokkel M, Stevens H, Taphoorn M, et al. Differentiation between recurrent brain tumour and post-radiation necrosis: the value of201Tl-SPECT versus 18F-FDG PET using a dual-headed coincidence camera—a pilot study. Nucl Med Commun 1999; 20:411–417.PubMed
25.
go back to reference Kaplan WD, Takvorian T, Morris JH, et al. Thallium-201 brain imaging: a comparative study with pathological correlation. J Nucl Med 1987; 28:47–52.PubMed Kaplan WD, Takvorian T, Morris JH, et al. Thallium-201 brain imaging: a comparative study with pathological correlation. J Nucl Med 1987; 28:47–52.PubMed
26.
go back to reference Sehweil AM, McKillop JH, Milroy R, et al. Mechanism of Tl-201 uptake in tumours. Eur J Nucl Med 1989; 15:376–379.PubMed Sehweil AM, McKillop JH, Milroy R, et al. Mechanism of Tl-201 uptake in tumours. Eur J Nucl Med 1989; 15:376–379.PubMed
27.
go back to reference Cicciarello R, d’Avella D, Gagliardi ME, et al. Time-related ultrastructural changes in an experimental model of whole brain irradiation. Neurosurgery 1996; 38:772–780.PubMed Cicciarello R, d’Avella D, Gagliardi ME, et al. Time-related ultrastructural changes in an experimental model of whole brain irradiation. Neurosurgery 1996; 38:772–780.PubMed
28.
go back to reference Brismar T, Collins VP, Kesselberg M. Thallium-201 uptake relates to membrane potential and potassium permeability in human glioma cells. Brain Res 1989; 500:30–36.CrossRefPubMed Brismar T, Collins VP, Kesselberg M. Thallium-201 uptake relates to membrane potential and potassium permeability in human glioma cells. Brain Res 1989; 500:30–36.CrossRefPubMed
29.
go back to reference Gomez-Río M, Martínez del Valle MD, Rodríguez-Fernández A, et al. Radionecrosis vs tumoral recurrence in brain tumors: diagnosis using Tl-201·SPECT [abstract]. Eur J Nucl Med 1998; 25:922. Gomez-Río M, Martínez del Valle MD, Rodríguez-Fernández A, et al. Radionecrosis vs tumoral recurrence in brain tumors: diagnosis using Tl-201·SPECT [abstract]. Eur J Nucl Med 1998; 25:922.
30.
go back to reference Martínez del Valle MD, Gómez-Río M, Rodríguez-Fernández A, et al. Usefulness of Tl-201 SPECT in the diagnosis of radionecrosis versus tumoral recurrence in low grade glial tumours [abstract]. Eur J Nucl Med 2002; 29 [Suppl 1]: S229. Martínez del Valle MD, Gómez-Río M, Rodríguez-Fernández A, et al. Usefulness of Tl-201 SPECT in the diagnosis of radionecrosis versus tumoral recurrence in low grade glial tumours [abstract]. Eur J Nucl Med 2002; 29 [Suppl 1]: S229.
31.
go back to reference Sabbah P, Foehrenbach H, Dutertre G, et al. Multimodal anatomic, functional and metabolic brain imaging for tumor resection. J Clin Imaging 2002; 26:6–12.CrossRef Sabbah P, Foehrenbach H, Dutertre G, et al. Multimodal anatomic, functional and metabolic brain imaging for tumor resection. J Clin Imaging 2002; 26:6–12.CrossRef
Metadata
Title
201Tl-SPECT in low-grade gliomas: diagnostic accuracy in differential diagnosis between tumour recurrence and radionecrosis
Authors
Manuel Gómez-Río
Dolores Martínez del Valle Torres
Antonio Rodríguez-Fernández
José Manuel Llamas-Elvira
Simeón Ortega Lozano
Carlos Ramos Font
Escarlata López Ramírez
Majed Katati
Publication date
01-09-2004
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 9/2004
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-004-1501-5

Other articles of this Issue 9/2004

European Journal of Nuclear Medicine and Molecular Imaging 9/2004 Go to the issue